Poging GOUD - Vrij

How Seed Funding is Driving Indian Pharma Startups

Bio Spectrum

|

BioSpectrum India Nov 2024

For pharmaceutical businesses in India, seed capital is more than just a financial boost; it is an essential component of long-term success. In order to draw in future investors, it assists businesses in innovating, scaling up, and overcoming regulatory obstacles. This has a beneficial knock-on impact and helps to create a healthier and more inventive future for India's health industry. Let's explore further.

- Dr Jay Doshi

How Seed Funding is Driving Indian Pharma Startups

Pharmaceutical startups looking for seed funding to turn their ideas into reality and develop solutions that improve patients’ lives benefit greatly from early-stage capital. Such capital would be spent on innovation, breakthroughs in drug discovery, AI-related health technologies, and personalised medicine. For example, the majority of India’s healthcare startups are focused on creating tech solutions that drive efficiency in the supply chain or improve patient outcomes. These startups have utilised seed funding to enhance their offerings, streamline operations, and deliver better healthcare solutions.

Seed funding plays a pivotal role in this growth trajectory, serving as the essential capital that ignites innovation and propels startups forward. For many emerging companies, access to early-stage capital is crucial for developing their proof of concept (POC) and attracting top talent. In a highly competitive market, having the right resources enables startups to innovate rapidly and respond to the evolving needs of the healthcare sector. As artificial intelligence (AI) and other advanced technologies reshape the healthcare industry, startups face constant pressure to adapt and enhance their offerings. This necessity for continuous innovation underscores the importance of securing seed funding, as it allows companies to invest in research and development (R&D), refine their technologies, and launch new products or services without the immediate burden of achieving profitability.

Beginning of Innovation

MEER VERHALEN VAN Bio Spectrum

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Bio Spectrum

Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr

Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.

time to read

1 min

February 2026

Bio Spectrum

146 Biosimilars in 25 Years: India at Global Scale

Biosimilars are an important part of modern therapeutics and a central component of India's shift beyond a generics-led pharmaceutical model.

time to read

8 mins

February 2026

Bio Spectrum

Decode Age raises Rs 14.48 Cr to advance longevity science and gut microbiome research

Bengaluru-based Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs 14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Havih Envirosciences announces partnership with Andhra Pradesh

Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC

Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

IIT-D and AIIMS develop swallowable microdevice for microbiome study

Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Care ADHD expands global operations with first GCC in India

Care ADHD, one of the United Kingdom's fastest growing digital mental health companies and a key partner to the NHS, has announced the opening of its first Global Capability Centre (GCC) in India - Bengaluru.

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size